Psychedelic Moral Enhancement
B. Earp
Royal Institute of Philosophy Supplement October 1, 2018 DOI: 10.1017/s1358246118000474 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Theoretical or philosophical paper Peer reviewed |
|---|---|
| Intervention | Psychedelic drugs |
| Key points | Argues that bioethicists have neglected an intermediate form of moral bioenhancement—the appropriately qualified use of certain psychedelic drugs—which may avoid the impracticality of radical proposals and the indistinguishability of more sensible ones from traditional moral education or cognitive enhancement. |
Abstract
Abstract The moral enhancement (or bioenhancement) debate seems stuck in a dilemma. On the one hand, the more radical proposals, while certainly novel and interesting, seem unlikely to be feasible in practice, or if technically feasible then most likely imprudent. But on the other hand, the more sensible proposals – sensible in the sense of being both practically achievable and more plausibly ethically justifiable – can be rather hard to distinguish from both traditional forms of moral enhancement, such as non-drug-mediated social or moral education, and non-moral forms of bioenhancement, such as smart-drug style cognitive enhancement. In this essay, I argue that bioethicists have paid insufficient attention to an alternative form of moral bioenhancement – or at least a likely candidate – that falls somewhere between these two extremes, namely the (appropriately qualified) use of certain psychedelic drugs.
Citations in the library
Cited by 25
- Ethics and ego dissolution: the case of psilocybin Journal of Medical Ethics May 27, 2020
- Ethical and Practical Considerations for the Use of Psychedelics in Psychiatry Psychiatric Services March 29, 2023
- Psychedelic unselfing: self-transcendence and change of values in psychedelic experiences Frontiers in Psychology June 14, 2023
- Psychedelic medicalization, public discourse, and the morality of ego dissolution International Journal of Cultural Studies June 9, 2021
- Moral Psychopharmacology Needs Moral Inquiry: The Case of Psychedelics Frontiers in Psychiatry August 2, 2021
and 20 more in the library
Cites 23
- Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance Psychopharmacology July 7, 2006
- Human hallucinogen research: guidelines for safety. Journal of Psychopharmacology July 1, 2008
- Differences Between the Mechanism of Action of MDMA, MBDB, and the Classic Hallucinogens. Identification of a New Therapeutic Class: Entactogens Journal of Psychoactive Drugs October 1, 1986
- Ayahuasca-Assisted Therapy for Addiction: Results from a Preliminary Observational Study in Canada Current Drug Abuse Reviews June 1, 2013
- ADVERSE REACTIONS TO PSYCHEDELIC DRUGS. A REVIEW OF THE LITERATURE The Journal of Nervous and Mental Disease October 1, 1984
and 18 more in the library